Kwashiorkor clinical trials

The registry lists 45 studies for Kwashiorkor across more than 10 countries. 5 are recruiting or about to start. 25 of them are mainly about Kwashiorkor (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Kwashiorkor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 32
Status unknown: 5
Recruiting: 3
Active, not recruiting: 2
Not yet recruiting: 2
Withdrawn: 1

Phase

Phase 3: 4
Phase 2: 2

Where

Malawi: 6
Burkina Faso: 3
Netherlands: 3
United States: 3
Kenya: 2
Germany: 2

Who runs them

Washington University School of Medicine (6) · University Ghent (3) · Baylor College of Medicine (2) · Maastricht University Medical Center (2) · University of California, San Francisco (2) · University of Oxford (2) · University Medicine Greifswald (1) · Azienda Ospedaliera Universitaria Integrata Verona (1)

What is being tested here

Drugs under test in Kwashiorkor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Protein Supplement	1	2
Egg as food	1	2
Amoxicillin	0	1
Cefdinir	0	1
Azithromycin	1	1
Human milk	0	1
Amino Acids	0	1
Albendazole	0	1

Coming up

1phase 3 study under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Jan 2027Choline to Improve Malnutrition and Enhance Cognition · Washington University School of Medicine

Who these studies take

Of the 3 Kwashiorkor studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (67%)	2 (67%)
30	2 (67%)	2 (67%)
40	2 (67%)	2 (67%)
50	2 (67%)	2 (67%)
65	3 (100%)	3 (100%)
75	3 (100%)	3 (100%)
85	3 (100%)	3 (100%)

Across all 45 studies, recruiting or not: 58% stop at 75 or younger and 56% at 65; 44% take children; 7% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Kwashiorkor studies take

Of 21 interventional studies with no phase under Kwashiorkor, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	20 mo10–24 · 21 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 45 of 45. search them.